Lymphoma, Extranodal NK-T-Cell
3 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Dibotatug for lymphoma, extranodal nk-t-cell | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Selinexor, anti-PD-1 antibody plus Golidocitinib for lymphoma, extranodal nk-t-cell | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| XPO1 inhibitor for lymphoma, extranodal nk-t-cell | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |